The Potential Therapeutic Effect of Orexin-Treated versus Orexin-Untreated Adipose Tissue-Derived Mesenchymal Stem Cell Therapy on Insulin Resistance in Type 2 Diabetic Rats

Table 2

Fasting glucose, insulin, and HOMA-IR profiles in different study groups.

Variables	Control group	T2DM group	AD-MSCs group	AD-MSCs pretreated with OXA group
Fasting glucose (mmol/l)		^a	^abc	^b
Insulin (mU/l)		^a	^abc	^ab
HOMA-IR		^a	^abc	^b

The results are reported as ; . as compared to the control group, as compared to the T2DM group, and as compared to AD-MSCs pretreated with the OXA group. T2DM group/T2DM: type 2 diabetes; AD-MSCs: adipose-derived mesenchymal stem cells; OXA: orexin A; HOMA-IR: homeostatic model assessment of insulin resistance index. The significance level was set at .